Výsledky vyhledávání - "Benjamin N Gross"

Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: an opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Autor: Sara Wilson Reece, Rick Hess, Jennifer N. Clements, Heather P. Whitley, Chad K Gentry, Jennifer J. D'Souza, Benjamin N. Gross, Kayce M. Shealy

Publikováno v: Current Medical Research and Opinion. 31:1733-1741

Type 2 diabetes mellitus (T2DM) carries a high prevalence in the United States and worldwide. Therefore, the number of medication classes being developed and studied has grown. The individualized management of diabetes is accomplished by evaluating a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c117db17a61fe226a2fcc70ca5a4a79
https://doi.org/10.1185/03007995.2015.1069739

Zobrazit plný text záznamu

Chapter 12: Hypertension

Autor: Benjamin N. Gross

Publikováno v: The APhA Complete Review for Pharmacy, 11th Edition
The APhA Complete Review for Pharmacy, 13th Edition ISBN: 1582123616

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdee9ba5afa5119dd52e8d92570ae44
https://doi.org/10.21019/9781582122816.ch12

Zobrazit plný text záznamu

Clinical Pearls for Initiating and Utilizing Liraglutide in Patients With Type 2 Diabetes

Autor: Benjamin N. Gross

Publikováno v: Journal of Pharmacy Practice. 26:144-150

This review presents clinical pearls for initiating liraglutide (Victoza®, Novo Nordisk Inc) therapy for the management of type 2 diabetes and selecting patients who will benefit from liraglutide therapy. Liraglutide, a once-daily glucagon-like pept

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95dd17f3b252beae73e712723e2cfa7
https://doi.org/10.1177/0897190012465985

Zobrazit plný text záznamu

Community Partners Join Forces: Battling Obesity and Diabetes Together

Autor: Winston Brooks, Nicole Nielsen, Jordan Wright, Benjamin N. Gross, Robin Parker

Publikováno v: Journal of community health. 42(2)

Our objectives was to create an initiative to change the culture of a small community to improve quality of life as it relates to health for the residents through the use of health-related educational sessions, a coordinated fitness and nutrition pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf34c26002c97731d255dd91da99fe70
https://pubmed.ncbi.nlm.nih.gov/27638034

Zobrazit plný text záznamu

Falsely Low Hemoglobin A1cLevels in a Patient Receiving Ribavirin and Peginterferon alfa-2b for Hepatitis C

Autor: L Brian Cross, Joni C Foard, Benjamin N Gross, Yelena A Wood

Publikováno v: Pharmacotherapy. 29:121-123

The effect of treatment for hepatitis C viral infection on hemoglobin A(1c) (A1C) levels is not well described in the literature. We describe a 59-year-old man with type 2 diabetes mellitus whose A1C level became falsely low when ribavirin and pegint

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a1861dfc5512ca86bff3014d6b6530d
https://doi.org/10.1592/phco.29.1.121

Zobrazit plný text záznamu

Pharmacist-physician collaboration for diabetes care: the diabetes initiative program

Autor: Michelle Z. Farland, Katie J. Suda, Debbie C. Byrd, Benjamin N. Gross, Christa M. George, Andrea S. Franks, Jeremy Thomas, Alexander B. Guirguis, M. Shawn McFarland

Publikováno v: The Annals of pharmacotherapy. 47(6)

BACKGROUND: Multiple complications can arise secondary to poor control of glucose, blood pressure, and cholesterol in a patient with diabetes. OBJECTIVE: To evaluate the effect of a pharmacist-physician collaboration on attainment of diabetes-related

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d626fb24e0acce5332514612764416
https://pubmed.ncbi.nlm.nih.gov/23656751

Zobrazit plný text záznamu

Potential drug interactions associated with treatments for type 2 diabetes and its comorbidities: a clinical pharmacology review

Autor: Jeffrey S. Freeman, Benjamin N Gross

Publikováno v: Expert review of clinical pharmacology. 5(1)

Type 2 diabetes is a disease of glucose metabolism that commonly involves multiple comorbidities, including lipid dyscrasias and hypertension. Each concurrent disorder contributes some risk of complications and requires therapeutic intervention. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd139c355182e37a971d90e3728c2fa7
https://pubmed.ncbi.nlm.nih.gov/22142157

Zobrazit plný text záznamu

Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic

Autor: L Brian Cross, U P Patel, Jeffrey Tunney, Benjamin N. Gross, M. Shawn McFarland, Chad . Gentry

Publikováno v: Journal of managed care pharmacy : JMCP. 15(7)

Sitagliptin is recommended for initial and maintenance dosing at 100 mg daily. Downward dose adjustment is recommended in patients with moderate or severe renal insufficiency.To determine the prevalence of the potentially inappropriate initial dosing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9f0ca2edf12fb623c5c30fbe69695d8
https://pubmed.ncbi.nlm.nih.gov/19739879

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání